OUR TEAM

Anil Sadarangani – PhD & MBA

CEO

With experience in business development in the regenerative medicine biotechnology industry, Anil has lead and managed functional teams from preclinical and translational research and has a broad-based understanding of overall drug discovery and development from preclinical discoveries to market.

Tomás Egaña – PhD

CSO

With a PhD in Pharmacology and a PhD in Human Biology, Tomás has broad experience in ​Regenerative Medicine and Biomaterials. He is the inventor of SymbiO-2´s technologies and leads the research area of the company.

Andrés Völker – MBA

CCO

With extensive experience in the development of new markets and new products, pricing products based on relevant information of each market and business line, development and implementation of marketing and advertising campaigns, and finance and administration.

Catalina Valencia

Ip Manager

With extensive experience working with start-ups in the strategic development of businessesand products, management of intellectual property portfolios and structuring and negotiation of complex transactions, Catalina was Senior Counsel for Genentech, the Biotech pioneer, during the early phase of research and development and expansion.